136 related articles for article (PubMed ID: 31902663)
1. Increased programmed death ligand-1 expression in metastatic Merkel cell carcinoma associates with better prognosis.
Nakamura M; Magara T; Nojiri Y; Nishihara H; Kato H; Teramoto Y; Yasuda M; Wada H; Ozawa T; Umemori Y; Ogata D; Kobayashi T; Hata M; Nagase K; Morita A
J Dermatol Sci; 2020 Feb; 97(2):165-167. PubMed ID: 31902663
[No Abstract] [Full Text] [Related]
2. Heterogeneity of programmed death-ligand expression in a case of Merkel cell carcinoma exhibiting complete regression after multiple metastases.
Nakamura M; Magara T; Kobayashi Y; Kato H; Watanabe S; Morita A
Br J Dermatol; 2019 May; 180(5):1228-1229. PubMed ID: 30431150
[No Abstract] [Full Text] [Related]
3. PD-L1 Expression and Tumor-Infiltrating Lymphocytes in High-Risk and Metastatic Cutaneous Squamous Cell Carcinoma.
Amoils M; Kim J; Lee C; Sunwoo JB; Colevas AD; Aasi SZ; Hollmig ST; Ma Y; Divi V
Otolaryngol Head Neck Surg; 2019 Jan; 160(1):93-99. PubMed ID: 30012051
[TBL] [Abstract][Full Text] [Related]
4. Merkel cell carcinoma in a male breast: a case report.
Alzaraa A; Thomas GD; Vodovnik A; Modgill VK
Breast J; 2007; 13(5):517-9. PubMed ID: 17760677
[TBL] [Abstract][Full Text] [Related]
5. Merkel cell carcinomas infiltrated with CD33
Kervarrec T; Gaboriaud P; Berthon P; Zaragoza J; Schrama D; Houben R; Le Corre Y; Hainaut-Wierzbicka E; Aubin F; Bens G; Domenech J; Guyétant S; Touzé A; Samimi M
J Am Acad Dermatol; 2018 May; 78(5):973-982.e8. PubMed ID: 29273486
[TBL] [Abstract][Full Text] [Related]
6. Decreased 5-hydroxymethylcytosine immunoreactivity in primary Merkel cell carcinoma is a strong predictor for disease-specific death.
Gambichler T; Schmitt K; Rüddel I; Dreibigacker M; Stockfleth E; Becker JC
Br J Dermatol; 2019 Aug; 181(2):389-390. PubMed ID: 30703276
[No Abstract] [Full Text] [Related]
7. [Merkel cell carcinoma].
Helmbold P; Schröter S; Holzhausen HJ; Dunst J; Marsch WCh
Hautarzt; 2002 Oct; 53(10):652-8. PubMed ID: 12297946
[TBL] [Abstract][Full Text] [Related]
8. Effects of surgery on survival of patients aged 75 years or older with Merkel cell carcinoma.
Ren K; Yin X; Zhou B
Cancer Med; 2022 Jan; 11(1):128-138. PubMed ID: 34821054
[TBL] [Abstract][Full Text] [Related]
9. Case series: Merkel cell carcinoma of the eyelid.
Bostan C; de Souza MBD; Zoroquiain P; de Souza LAG; Burnier MN
Can J Ophthalmol; 2017 Oct; 52(5):e182-e185. PubMed ID: 28985829
[No Abstract] [Full Text] [Related]
10. Avelumab in patients with chemotherapy-refractory metastatic Merkel cell carcinoma: a multicentre, single-group, open-label, phase 2 trial.
Kaufman HL; Russell J; Hamid O; Bhatia S; Terheyden P; D'Angelo SP; Shih KC; Lebbé C; Linette GP; Milella M; Brownell I; Lewis KD; Lorch JH; Chin K; Mahnke L; von Heydebreck A; Cuillerot JM; Nghiem P
Lancet Oncol; 2016 Oct; 17(10):1374-1385. PubMed ID: 27592805
[TBL] [Abstract][Full Text] [Related]
11. [Merkel cell tumor of the skin].
Lucev M
Minerva Chir; 1988 Oct; 43(20):1779-80. PubMed ID: 3231327
[No Abstract] [Full Text] [Related]
12. Lower expression of CADM1 and higher expression of MAL in Merkel cell carcinomas are associated with Merkel cell polyomavirus infection and better prognosis.
Iwasaki T; Matsushita M; Nonaka D; Nagata K; Kato M; Kuwamoto S; Murakami I; Hayashi K
Hum Pathol; 2016 Feb; 48():1-8. PubMed ID: 26772392
[TBL] [Abstract][Full Text] [Related]
13. p63 expression in Merkel cell carcinoma predicts poorer survival yet may have limited clinical utility.
Stetsenko GY; Malekirad J; Paulson KG; Iyer JG; Thibodeau RM; Nagase K; Schmidt M; Storer BE; Argenyi ZB; Nghiem P
Am J Clin Pathol; 2013 Dec; 140(6):838-44. PubMed ID: 24225752
[TBL] [Abstract][Full Text] [Related]
14. Progress toward diminishing the murkiness of Merkel cell carcinoma management.
Heymann WR
J Am Acad Dermatol; 2021 Feb; 84(2):263-264. PubMed ID: 33290802
[No Abstract] [Full Text] [Related]
15. Surgical invasion resulted in increased programmed death ligand 1 expression in a case of multicentric Merkel cell carcinoma with six primary lesions.
Yoshimitsu M; Nakamura M; Oda T; Kato H; Morita A
J Dermatol; 2020 Aug; 47(8):e305-e307. PubMed ID: 32548896
[No Abstract] [Full Text] [Related]
16. Clinical approach to neuroendocrine carcinoma of the skin (Merkel cell carcinoma).
Smith DF; Messina JL; Perrott R; Berman CG; Reintgen DS; Cruse CW; Glass FL; Fenske NA; DeConti RC; Trotti A
Cancer Control; 2000; 7(1):72-83. PubMed ID: 10740663
[No Abstract] [Full Text] [Related]
17. Merkel cell carcinoma of the head and neck: poorer prognosis than non-head and neck sites.
Morand GB; Madana J; Da Silva SD; Hier MP; Mlynarek AM; Black MJ
J Laryngol Otol; 2016 Apr; 130(4):393-7. PubMed ID: 26875509
[TBL] [Abstract][Full Text] [Related]
18. Impact of total radiotherapy dose on survival for head and neck Merkel cell carcinoma after resection.
Patel SA; Qureshi MM; Mak KS; Sahni D; Giacalone NJ; Ezzat W; Jalisi S; Truong MT
Head Neck; 2017 Jul; 39(7):1371-1377. PubMed ID: 28370725
[TBL] [Abstract][Full Text] [Related]
19. [Merkel cell carcinoma: a diagnostic and therapeutic challenge].
Helmbold P; Schröter S; Holzhausen HJ; Hartschuh W; Marsch WC
Chirurg; 2001 Apr; 72(4):396-401. PubMed ID: 11357530
[TBL] [Abstract][Full Text] [Related]
20. [Merkel cell carcinoma of the skin: two case reports located at the hand, with a review of litterature].
Degeorges R; Reynaud C; Welby F; Belkheyar Z; Abbey-Toby A; Alnot JY
Chir Main; 2006 Feb; 25(1):22-6. PubMed ID: 16610517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
